Pages that link to "Q43426670"
Jump to navigation
Jump to search
The following pages link to Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection (Q43426670):
Displaying 50 items.
- Heliox inhalation therapy for bronchiolitis in infants (Q24187117) (← links)
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Q24235515) (← links)
- Heliox inhalation therapy for bronchiolitis in infants (Q24235919) (← links)
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Q24242993) (← links)
- Heliox inhalation therapy for bronchiolitis in infants (Q24243023) (← links)
- Immunoglobulin for preventing respiratory syncytial virus infection (Q24245599) (← links)
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Q24246151) (← links)
- Respiratory viruses other than influenza virus: impact and therapeutic advances (Q24655957) (← links)
- Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis (Q24679785) (← links)
- Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective (Q26830864) (← links)
- The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection (Q26864494) (← links)
- Recent advances in management of bronchiolitis (Q27002560) (← links)
- Impact of respiratory syncytial virus: the nurse's perspective (Q27023799) (← links)
- Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease (Q28067464) (← links)
- Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries (Q28069415) (← links)
- Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease (Q28072535) (← links)
- Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel. (Q30359775) (← links)
- Immunohistochemical assessment of respiratory viruses in necropsy samples from lethal non-pandemic seasonal respiratory infections (Q30394215) (← links)
- Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants (Q31047460) (← links)
- A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection (Q33478019) (← links)
- Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma (Q33605739) (← links)
- Noninvasive ventilation in acute respiratory failure from respiratory syncytial virus bronchiolitis (Q33653175) (← links)
- Analysis of antibiotic use and misuse in children hospitalized with RSV infection. (Q33686706) (← links)
- Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus (Q33859103) (← links)
- Respiratory syncytial virus infections in infants affected by primary immunodeficiency. (Q33892605) (← links)
- Immunoglobulin for preventing respiratory syncytial virus infection. (Q33909278) (← links)
- Respiratory syncytial virus immunoprophylaxis: impact on epidemiology (Q33999183) (← links)
- Prevention of respiratory syncytial virus infections (Q34342190) (← links)
- Review of treatment of bronchiolitis related apnoea in two centres (Q34396438) (← links)
- Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam (Q34561958) (← links)
- A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice (Q34884984) (← links)
- Severe viral respiratory infections: are bugs bugging? (Q35039520) (← links)
- Current strategies in the prevention of respiratory syncytial virus disease (Q35076967) (← links)
- Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children (Q35157930) (← links)
- Current treatment for acute viral bronchiolitis in infants (Q35183760) (← links)
- Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children (Q35219139) (← links)
- Antibiotic prescribing pattern in paediatric in patients with first time wheezing (Q35230378) (← links)
- Local variability in respiratory syncytial virus disease severity (Q35257342) (← links)
- Association of fever and severe clinical course in bronchiolitis (Q35264595) (← links)
- Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children (Q35466073) (← links)
- Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease (Q35582853) (← links)
- Vaccines in pregnancy: a review of their importance in Brazil (Q35604292) (← links)
- Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus. (Q35625850) (← links)
- Epidemiology of respiratory syncytial virus infection in preterm infants (Q35673550) (← links)
- Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection. (Q35688311) (← links)
- Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention (Q35735115) (← links)
- High pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infants (Q35959972) (← links)
- Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease (Q35987805) (← links)
- Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town (Q36035788) (← links)
- Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics (Q36093377) (← links)